|
1.
|
Rice-Evans C: Implications of the
mechanisms of action of tea polyphenols as antioxidants in vitro
for chemoprevention in humans. Proc Soc Exp Biol Med. 220:262–266.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Wiseman SA, Balentine DA and Frei B:
Antioxidants in tea. Crit Rev Food Sci Nutr. 37:705–718. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Muto S, Yokoi T, Gondo Y, et al:
Inhibition of benzo[a]pyrene- induced mutagenesis by
(-)-epigallocatechin gallate in the lung of rpsL transgenic mice.
Carcinogenesis. 20:421–424. 1999.
|
|
4.
|
Yang GY, Liao J, Kim K, Yurkow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Okabe S, Ochiai Y, Aida M, et al:
Mechanistic aspects of green tea as a cancer preventive: effect of
components on human stomach cancer cell lines. Jpn J Cancer Res.
90:733–739. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Setiawan VW, Zhang ZF, Yu GP, et al:
Protective effect of green tea on the risks of chronic gastritis
and stomach cancer. Int J Cancer. 92:600–604. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Rao DN, Ganesh B, Dinshaw KA and Mohandas
KM: A case- control study of stomach cancer in Mumbai, India. Int J
Cancer. 99:727–731. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Masuda M, Suzui M and Weinstein IB:
Effects of epigallocatechin-3-gallate on growth, epidermal growth
factor receptor signaling pathways, gene expression, and
chemosensitivity in human head and neck squamous cell carcinoma
cell lines. Clin Cancer Res. 7:4220–4229. 2001.
|
|
9.
|
Masuda M, Suzui M, Lim JT and Weinstein
IB: Epigallocatechin- 3-gallate inhibits activation of HER-2/neu
and downstream signaling pathways in human head and neck and breast
carcinoma cells. Clin Cancer Res. 9:3486–3491. 2003.PubMed/NCBI
|
|
10.
|
Liang YC, Lin-Shiau SY, Chen CF and Lin
JK: Suppression of extracellular signals and cell proliferation
through EGF receptor binding by (-)-epigallocatechin gallate in
human A431 epidermoid carcinoma cells. J Cell Biochem. 67:55–65.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Liang G, Tang A, Lin X, et al: Green tea
catechins augment the antitumor activity of doxorubicin in an in
vivo mouse model for chemoresistant liver cancer. Int J Oncol.
37:111–123. 2010.PubMed/NCBI
|
|
12.
|
Seki H, Ozaki T and Shiina M: Side-hole
catheter placement for hepatic arterial infusion chemotherapy in
patients with liver metastases from colorectal cancer: long-term
treatment and survival benefit. AJR Am J Roentgenol. 190:111–120.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Sonoda J, Koriyama C, Yamamoto S, et al:
HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1
carriers is diminished by green tea drinking. Cancer Sci.
95:596–601. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Mantovani G, Macciò A, Madeddu C, et al:
Antioxidant agents are effective in inducing lymphocyte progression
through cell cycle in advanced cancer patients: assessment of the
most important laboratory indexes of cachexia and oxidative stress.
J Mol Med (Berl). 81:664–673. 2003. View Article : Google Scholar
|
|
15.
|
Conklin KA: Chemotherapy-associated
oxidative stress: impact on chemotherapeutic effectiveness. Integr
Cancer Ther. 3:294–300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lamson DW and Brignall MS: Antioxidants in
cancer therapy; their actions and interactions with oncologic
therapies. Altern Med Rev. 4:304–329. 1999.PubMed/NCBI
|
|
17.
|
Quiles JL, Huertas JR, Battino M, Mataix J
and Ramírez-Tortosa MC: Antioxidant nutrients and adriamycin
toxicity (Review). Toxicology. 180:79–95. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Moss RW: Should patients undergoing
chemotherapy and radiotherapy be prescribed antioxidants? Integr
Cancer Ther. 5:63–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lamson DW and Brignall MS: Antioxidants
and cancer, part 3: quercetin. Altern Med Rev. 5:196–208.
2000.PubMed/NCBI
|
|
20.
|
Lamson DW and Brignall MS: Antioxidants
and cancer therapy II: quick reference guide. Altern Med Rev.
5:152–163. 2000.PubMed/NCBI
|
|
21.
|
Lamson DW and Brignall MS: Natural agents
in the prevention of cancer. Part 1: human chemoprevention trials.
Altern Med Rev. 6:7–19. 2001.PubMed/NCBI
|
|
22.
|
Pathak AK, Bhutani M, Guleria R, et al:
Chemotherapy alone vs. chemotherapy plus high dose multiple
antioxidants in patients with advanced non small cell lung cancer.
J Am Coll Nutr. 24:16–21. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Pathak AK, Singh N, Khanna N, Reddy VG,
Prasad KN and Kochupillai V: Potentiation of the effect of
paclitaxel and carboplatin by antioxidant mixture on human lung
cancer h520 cells. J Am Coll Nutr. 21:416–421. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Drisko JA, Chapman J and Hunter VJ: The
use of antioxidant therapies during chemotherapy (Review). Gynecol
Oncol. 88:434–439. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Kanaoka Y, Inagaki E, Hamanaka S, Masaki H
and Tanemoto K: Analysis of reactive oxygen metabolites (ROMs)
after cardiovascular surgery as a marker of oxidative stress. Acta
Med Okayama. 64:323–330. 2010.PubMed/NCBI
|
|
26.
|
Cesarone MR, Belcaro G, Carratelli M, et
al: A simple test to monitor oxidative stress. Int Angiol.
18:127–130. 1999.
|
|
27.
|
Nakayama K, Terawaki H, Nakayama M,
Iwabuchi M, Sato T and Ito S: Reduction of serum antioxidative
capacity during hemodialysis. Clin Exp Nephrol. 11:218–224. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kono S, Ikeda M, Tokudome S and Kuratsune
M: A case-control study of gastric cancer and diet in northern
Kyushu, Japan. Jpn J Cancer Res. 79:1067–1074. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ohno Y, Wakai K, Genka K, et al: Tea
consumption and lung cancer risk: a case-control study in Okinawa,
Japan. Jpn J Cancer Res. 86:1027–1034. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Imai K, Suga K and Nakachi K:
Cancer-preventive effects of drinking green tea among a Japanese
population. Prev Med. 26:769–775. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Kimura M, Umegaki K, Kasuya Y, Sugisawa A
and Higuchi M: The relation between single/double or repeated tea
catechin ingestions and plasma antioxidant activity in humans. Eur
J Clin Nutr. 56:1186–1193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Koren E, Kohen R and Ginsburg I:
Polyphenols enhance total oxidant-scavenging capacities of human
blood by binding to red blood cells. Exp Biol Med (Maywood).
235:689–699. 2010. View Article : Google Scholar : PubMed/NCBI
|
